Guidelines for Newborn Screening of Congenital Hypothyroidism (2021 Revision)

Area of Science:

• Pediatric Endocrinology
• Neonatal Screening

Background:

• Newborn screening for congenital hypothyroidism (CH) began in Japan in 1979, significantly improving intellectual outcomes.
• The incidence of CH has risen due to the inclusion of subclinical cases in screening.
• Accurate diagnosis and specialized treatment are crucial to prevent unnecessary interventions.

Purpose of the Study:

• To update the 2014 Guidelines for Mass Screening of Congenital Hypothyroidism.
• Incorporate recent findings into the existing screening and management protocols.
• Provide clear guidance for the diagnosis and treatment of primary congenital hypothyroidism.

Main Methods:

• Minor revisions to the 2014 guidelines.
• Inclusion of the latest scientific findings and clinical recommendations.
• Focus on differential diagnosis and appropriate management strategies.

Main Results:

• Enhanced diagnostic criteria for congenital hypothyroidism.
• Refined protocols for managing patients identified through newborn screening.
• Updated recommendations for continuous treatment and specialized care.

Conclusions:

• The revised guidelines support accurate and timely diagnosis of CH.
• Ensures appropriate management, minimizing unnecessary treatments.
• Aims to optimize the long-term prognosis for individuals with congenital hypothyroidism.